Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Koral Shah
Institutions:
City Of Hope National Medical Center,
City of Hope
Observed institutions:
City Of Hope National Medical Center,
City of Hope
ORCID:
0000-0002-4868-8276
Observed ORCID:
0000-0002-4868-8276
OpenAlex ID:
A5136362101
Vulnerability index impacts distribution of prostate cancer clinical trials in the United States
2026
·
Vitor Abreu de Goes
, Benjamin Mercier
, et al.
·
Frontiers in Oncology
PDF
18 Prediction of Immune-Related Adverse Events (irAEs) with Hematologic Markers in Patients Receiving First-Line Immune Checkpoint Inhibitor (ICI)-Based Therapy in Metastatic Renal Cell Carcinoma (mRCC)
2026
·
Rahul Winayak
, Xiaochen Li
, et al.
·
The Oncologist
PDF
64 GPR65 is a Novel Therapeutic Target Associated with Immune Exhaustion in Clear Cell Renal Cell Carcinoma
2026
·
Nicholas Salgia
, Koral Shah
, et al.
·
The Oncologist
PDF
Genomic Characterization of Urothelial Carcinoma and Sarcomatoid Carcinoma of the Upper Urinary Tract
2026
·
Salvador Jaime-Casas
, Nicholas J. Salgia
, et al.
·
Cancers
PDF
Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing ALK Alteration Prolongs Treatment Duration
2026
·
Vitor Abreu de Góes
, Matthew Lee
, et al.
·
JCO Precision Oncology
Show more works
View as search
Works count:
5
Citation count:
H-index:
I10-index:
Year
Topic
Type